In addition, highly metastatic hormone receptor–negative breast cancer cells showed decreased cell migration and glucocorticoid sensitivity compared to parental cells with an accompanying decrease in GR expression and decreased glucocorticoid-responsive gene expression [200]. This evidence concerns the gene NR3C1 and breast cancer.